Pfizer (PFE) to Acquire Privately-Held Amplyx Pharmaceuticals Apr 28, 2021 06:47AM
Form SC 13D Reneo Pharmaceuticals, Filed by: New Enterprise Associates 15, L.P. Apr 23, 2021 08:47AM
Lumos Pharma (LUMO) Announces Retirement of Carl Langren and Names Lori Lawley CFO in Planned Succession Apr 20, 2021 04:14PM
Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P. Apr 14, 2021 06:03AM
Form SC 13D/A Millendo Therapeutics, Filed by: New Enterprise Associates 15, L.P. Apr 13, 2021 10:06AM
View Older Stories

Apr 9, 2021 01:46PM Sanofi (SNY) Acquires Tidal Therapeutics for $160M Upfront and Up to $310M in Milestones
Mar 26, 2021 10:38AM Form SC 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Mar 11, 2021 06:05AM Form SC 13D/A TREVENA INC Filed by: New Enterprise Associates 12, Limited Partnership
Mar 11, 2021 06:03AM Form SC 13D/A Viracta Therapeutics, Filed by: New Enterprise Associates 12, Limited Partnership
Mar 11, 2021 06:03AM Form SC 13D/A Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P.
Mar 11, 2021 06:03AM Form SC 13D/A DZS INC. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Mar 11, 2021 06:03AM Form SC 13D/A Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
Mar 8, 2021 06:16AM Quantum Computing Company IonQ to Merge with SPAC dMY Technology Group, Inc. III (DMYI)
Mar 8, 2021 06:00AM IonQ To Become The First Publicly Traded Pure-Play Quantum Computing Company
Mar 5, 2021 07:00AM Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Present at Upcoming Conferences
Mar 4, 2021 04:00PM Résultats annuels 2020 : Avancées majeures dans la NASH et visibilité financière significativement étendue suite au succès de l’introduction en bourse aux États Unis
Mar 4, 2021 04:00PM 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States
Mar 4, 2021 09:05AM Lumos Pharma (LUMO) Says Data Supporting Use of Predictive Enrichment Markers for its LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Hydrus Microstent Now First MIGS Device Proven With 5-Year Pivotal Trial Data; Results Show Over 60% Reduction in Secondary Glaucoma Surgeries, Sustained Reduction in Medication Use
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 3, 2021 12:00PM OmniSci Launches Free Edition of Platform to Democratize the Power of Accelerated Analytics
Mar 3, 2021 09:00AM Humana and the University of Houston Announce New Value-based Care Specialization Program
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 2, 2021 08:30AM Nuvolo Raises $31M Series C Funding to Accelerate Global Expansion and IWMS Platform Evolution
Mar 1, 2021 07:05AM Satsuma Pharmaceuticals Inc. (STSA) Announces $80 Million Private Placement Financing
Mar 1, 2021 07:00AM Satsuma Pharmaceuticals Announces $80 Million Private Placement Financing
Feb 25, 2021 08:00AM Appili Therapeutics to Host Drs. Scott Gottlieb and Syra Madad in Virtual Fireside Chat Discussing COVID-19: What We’ve Learned About Pandemic Responses, and Where We Go From Here
Feb 24, 2021 02:18PM Form SC 13D Metromile, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Feb 24, 2021 09:00AM Woebot Health Forms Clinical Diversity Advisory Board
Feb 24, 2021 06:15AM SoftBank-backed robotics firm Berkshire Grey to go public via $2.7 billion SPAC deal
Feb 24, 2021 06:13AM AI Developer Berkshire Grey Announces Business Combination with SPAC Revolution Acceleration Acquisition Corp (RAAC)
Feb 24, 2021 06:00AM Berkshire Grey, a Leader in AI-Enabled Robotics and Automation Solutions, Announces Business Combination with Revolution Acceleration Acquisition Corp
Feb 23, 2021 01:18PM Lightbank Closes New Venture Capital Fund, Raising $180 Million
Feb 23, 2021 09:00AM Topia Survey: 28% of Employees Worked Outside Their Home State or Country During the Pandemic, But Only 1/3 Reported It to HR
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 22, 2021 02:02PM Winner of the AIM-HI Accelerator Fund's Inaugural Women's Venture Competition Announced
Feb 18, 2021 01:59PM Appili Therapeutics to Host Series of Virtual Fireside Chats; First Event to Feature Dr. Scott Gottlieb to Discuss Critical Need for More Options to Combat COVID-19
Feb 18, 2021 09:13AM Sentry Raises $60 Million in Series D Funding at $1 Billion Valuation
Feb 18, 2021 08:00AM Avoro Ventures Adds Sara Nayeem, MD, as a Partner
Feb 17, 2021 10:30AM Cartus Joins Forces with Topia to Offer First-of-its-Kind Distributed Workforce Compliance Solution
Feb 17, 2021 09:53AM CIT GAP Funds Invests in Sweetie Boy Delivers to Simplify Transportation Needs for Automotive Dealers
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 12, 2021 01:30PM Form SC 13G Inozyme Pharma, Inc. Filed by: New Enterprise Associates 15, L.P.
Feb 12, 2021 01:30PM Form SC 13G Annexon, Inc. Filed by: New Enterprise Associates 15, L.P.
Feb 12, 2021 01:29PM Form SC 13G/A Surface Oncology, Inc. Filed by: New Enterprise Associates 14, L.P.
Feb 12, 2021 01:28PM Form SC 13G/A Sprout Social, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Feb 12, 2021 01:27PM Form SC 13G/A Cloudflare, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Feb 12, 2021 10:57AM BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q3 Financial Report, Clinical Studies Update
Feb 11, 2021 04:30PM VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
Feb 11, 2021 04:30PM VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
Feb 11, 2021 09:30AM Ascletis Joins Sagimet's US$80 Million in Crossover Financing with Premium Investors
View Older Stories